Drug
Afimetoran clinical trials
Also written BMS-986256.
- studies test it
- 12
- open now
- 1
- in phase 3
- 1
- first study started
- 2018
Keep track of what changes. Save the afimetoran studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
12 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 2
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Bristol-Myers Squibb (10) · Beeline Medicines Corporation (2)
Often tested with
Tested in the same studies.
Famotidine (3) · Phenytoin (1) · Midazolam (1) · Mycophenolic Acid (1) · Itraconazole (1)
Studies
Open first, then newest update. How each study uses afimetoran is read from its arms, and is right about nine times in ten.
Testing it · 12
- Phase 2/3 Double-Blind, Placebo-Controlled Study of Afimetoran in Cutaneous Lupus ErythematosusNot yet recruitingPhase 2/3Beeline Medicines CorporationNCT07881120Written as Afimetoran
- A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Active, not recruitingPhase 2Beeline Medicines CorporationNCT04895696Written as Afimetoran
- A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05866627Written as Afimetoran
- Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04470778Written as BMS-986256
- A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of MidazolamCompletedPhase 1Bristol-Myers SquibbNCT05901714Written as Afimetoran
- A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus ErythematosusCompletedPhase 1Bristol-Myers SquibbNCT04493541Written as BMS-986256
- A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04016753Written as BMS-986256
- A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04941755Written as BMS-986256
- Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04269356Written as BMS-986256
- Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate MofetilCompletedPhase 1Bristol-Myers SquibbNCT04039373Written as BMS-986256
- An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT03634995Written as BMS-986256
- A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT03950960Written as BMS-986256
Codes
What other systems call afimetoran · ClinicalTrials.gg INT017219
- UNII (FDA) LXP7MZL0VFAFIMETORANOne source FDA
- NCI Thesaurus C177089AfimetoranOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LXP7MZL0VF | AFIMETORAN | One source FDA |
| NCI Thesaurus | C177089 | Afimetoran | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.